Biocodex appoints new VP, managing director
SAN BRUNO, Calif. Biocodex, manufacturer of Florastor and Florastor Kids probiotic supplements, on Thursday announced the appointment of Marc Rohman as VP and managing director of Biocodex, Inc., the French company’s U.S. subsidiary.
According to Nicolas Coudurier, international director of Biocodex, the U.S. market is a key priority for the company for its planned strategic expansion in the pharmaceutical arena.
“Florastor has been a tremendous success worldwide, and we feel there is great potential for the U.S. to be one of our largest footprints for this and other brands,” Coudurier said. “We’re thrilled to have someone with [Rohman’s] vast pharma expertise, not only on the marketing side, but also on the medical affairs side, to lead our foray into new U.S. product offerings.”
Prior to joining Biocodex, Rohman was part of the senior management team at FlowMedica where he was responsible for directing the company’s collaboration efforts for targeted renal therapy. While at FlowMedica, he also directed the collaborative pharma and other general business development efforts, as well as lead marketing, market development and general promotion of the company.
“Maximizing the potential of the Florastor brand is going to be a key priority for me, but at the same time, I will also be focusing on strategic alliances to build the company’s U.S. portfolio,” Rohman said. “Within the next five years or so, I’d like to see the U.S. arm of Biocodex bring at least two or more products to market.”
In addition to his work at FlowMedica, Rohman also worked for leading biotech and pharmaceutical companies, such as Scios, which was acquired by Johnson & Johnson in 2003, Mallinckrodt (now Tyco Healthcare), Boehringer Mannheim, Knoll Pharmaceuticals and Marion Labs.
Rohman holds a Bachelor of Arts degree in advertising from Michigan State University.
CHPA introduces StopMedicineAbuse.org widget
WASHINGTON The Consumer Healthcare Products Association recently introduced a StopMedicineAbuse.org widget to help spread the word about teen cough medicine abuse.
The widget is an application that allows partners, bloggers and allies to share the StopMedicineAbuse resources by adding it to their web sites or blogs. The association’s approach to preventing teen cough medicine abuse includes the StopMedicineAbuse.org web and mobile sites, Facebook, the FiveMoms Campaign online.
McNeil Consumer Healthcare wants Americans to enjoy ‘the great outdoors’
FORT WASHINGTON, Pa. McNeil Consumer Healthcare and the National Park Foundation on Monday announced a partnership designed to encourage everyone, including people with allergies, to pledge to spend more time enjoying outdoor moments with friends and family.
To kick off the campaign, Discovery Channel’s international explorer and wilderness survival expert, Josh Bernstein, set up camp at Floyd Bennett Field in Brooklyn, N.Y., on April 17, reminding people that spring is the perfect time to start enjoying the outdoors, and camping is a great way to do just that.
“We are proud to partner with the National Park Foundation to protect our parks and encourage everyone to visit these very special places,” stated Jorge Leon, Benadryl product director. “We understand that for people with allergies, enjoying time in one of America’s National Parks, or any outdoor destination, may take just a little more planning, but the outdoor moments you enjoy with friends and family make it worth it.”
As part of the partnership, McNeil is donating $200,000 to the NPF. In addition, until June 15, a $1 donation will be made each time someone visits www.BenadrylMoments.com and enters a unique promotion code found on specially marked packages of Benadryl. Consumers are also encouraged to visit www.BenadrylMoments.com where they can pledge to enjoy a moment outdoors.